Renowned Speakers - Vaccines Immunization 2020
Pierre A. Morgon
CEO & Founder, MRGN Advisors. Switzerland
Matthias Giese
CEO & Founder, Institute for Molecular Vaccines Germany
Maurizio Chiriva-Internati
Director of the Basic and Translational research Texas Tech University Health Sciences Center. USA
Dennis Christensen
Senior Scientist Head of Vaccine Adjuvant Research , Infectious Disease Immunology Center for Vaccine Research Statens Serum Institut Denmark
Akira Homma
Chairman Policy and Strategy Council, Bio-Manguinhos/Fiocruz Brazil Brazil
Charles J. Arntzen
Arizona State University USA USA
Emmanuel Drouet
Professor of Virology, University Grenoble-Alpes, France France
Rene Labatut
Vice President Global Manufacturing Technology sanofi pasteur France France
Giulio F. Tarro
President, Foundation T. & L. de Beaumont Bonelli for cancer research, Italy Italy
Marek Malecki
President - Phoenix Biomolecular Engineering Foundation Principal Investigator at the National Institutes of Health University of Utrecht. USA
Marc Paul Girard
Honorary Professor, Paris 7 Denis Diderot University Member of the French National Academy of Medicine and French Veterinary Academy, France France
Giampietro Corradin
Group leader, University of Lausanne, Switzerland Switzerland
De-chu Christopher Tang
Founder VaxDome LLC & Vaxin Inc. USA
Raveendran Pottathil
President of Accudx Inc, Florida International University. USA
Maurizio Zanetti
Director of tumor immunology for the UCSD Center for Immunology University of California, San Diego. USA
Timothy R. Fouts
Senior Director, Virology, Profectus BioSciences. USA
Stephen Albert Johnston
Director - Innovations in Medicine Arizona State University. USA
Luigi Aurisicchio
Chief Executive Officer and Chief Scientific Officer Takis S.r.l. Italy
Peter Timms
Professor of Microbiology, University of the Sunshine Coast. Australia
Sheikh Mohammad Fazle Akbar
Principal Investigator, Toshiba General Hospital. Japan
Michael G. Hanna
Founder, Chairman Emeritus Vaccinogen Inc., USA Discoverer - Developer, OncoVAX® Director: Frederick Cancer Research Center (1975-1983) USA
Haval Shirwan
Chair in Autoimmune Disease Department of Microbiology and Immunology Director of the Molecular Immunomodulation Program at the Institute for Cellular Therapeutics University of Louisville USA
Jagat R Kanwar
Professor in Nanomedicine, Deakin University Melbourne Area. Australia
Michael Vajdy
Co-founder, Principal and Chief Scientific Officer Mucosal Immunologist and Vaccinologist EpitoGenesis, Inc. USA
William B. Smith
President of New Orleans Center, Professor of Medicine, University of Tennessee Medical Center. USA
Refat Sadeq
Professor, Port Said University Egypt
Magdalena Tary-Lehmann
Chief Scientific Officer & Co-Founder of Cellular Technology (CTL) Limited. USA
Yuzhang Wu
Director, Institute of Immunology, Third Military Medical University. China
Frederic J. Deschamps
Director, University Hospital of Reims. France
Pascal Breton
President & Chief Executive Officer, VitamFero S.A. France
Robert Lambkin-Williams
Executive Scientific Advisor, hVIVO. UK
Ger Rijkers
Professor in Biomedical and Life Sciences, Head of the Department of Sciences, University College Roosevelt. Netherlands
Nathalie Garçon
Chief Executive and Chief Scientific Officer, BIOASTER. France
Eduard Karamov
Head of Laboratory of Immunochemistry of the Gamaleya Center of Epidemiology and Microbiology of the Russian Ministry of Health" Russia
Indresh K. Srivastava
Vice President, Process and Analytical Development, Protein Sciences Corporation. USA
XL (Xiangliang) Lin
Founder, President / CEO VacciXcell. Singapore
Geert Vanden Bossche
Chief Innovation & Scientific Officer Univac. Belgium
Alireza Heidari
Director, California South University. USA
Cyril Gerard Gay
Senior National Program Leader United States Department of Agriculture USA
Masoud H. Manjili
Associate Professor of Pathology, Virginia Commonwealth University. USA
Brian Abel
Head, Immunogenomics Core SIgN, A*STAR Singapore
Mark Tomai
Head of TLR and MTS Business Development 3M Drug Delivery Systems. USA
Barry Buckland
CEO, BiologicB. USA